Weiyun Wang

机构：Mirna Therapeutics (United States), Third Affiliated Hospital of Zhengzhou University, Henan Medical University · ORCID：0000-0001-7152-1565

发表论文 40 篇 · 总被引 585 次 · h-index 12

代表论文

• Regeneration of articular cartilage defects: Therapeutic strategies and perspectives (2023 · Journal of Tissue Engineering · 被引 104)
• Targeting macrophage polarization as a promising therapeutic strategy for the treatment of osteoarthritis (2023 · International Immunopharmacology · 被引 71)
• Human expandable pancreatic progenitor–derived β cells ameliorate diabetes (2022 · Science Advances · 被引 71)
• A fast chemical reprogramming system promotes cell identity transition through a diapause-like state (2023 · Nature Cell Biology · 被引 28)
• Small cytosolic double-stranded DNA represses cyclic GMP-AMP synthase activation and induces autophagy (2023 · Cell Reports · 被引 20)
• N6-methyladenosine modification-mediated mRNA metabolism is essential for human pancreatic lineage specification and islet organogenesis (2022 · Nature Communications · 被引 20)